Skip to Content
MilliporeSigma
All Photos(1)

Documents

GE17-1440-02

Ficoll® Paque Plus

Cytiva 17-1440-02, pack of 6 × 100 mL

Synonym(s):

Ficoll density gradient medium, cell culture media

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352201
NACRES:
NA.25

form

liquid

packaging

pack of 6 × 100 mL

manufacturer/tradename

Cytiva 17-1440-02

color

Colorless to slightly yellow

pH range

5.5-7.5

General description

Ficoll-Paque Plus is a recognized standard in laboratories worldwide for the isolation of human lymphocytes for in vitro studies.

Ficoll-Paque PLUS is a ready to use, sterile medium for isolation of lymphocytes in high yield from peripheral blood using a simple and rapid centrifugation procedure. It maintains the viability and a representative distribution of B and T lymphocytes.

Application

For in vitro isolation of lymphocytes from human peripheral blood.

Features and Benefits

  • Ready to use sterile medium for isolation of human lymphocytes in high yield from peripheral blood.
  • Maintains viability and representative distribution of B and T lymphocytes.
  • Low levels of endotoxin (< 0.12 EU/mL).

Storage and Stability

Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.
Store at 4 to 30 °C ()

Analysis Note

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

Legal Information

Ficoll is a registered trademark of Cytiva

pictograms

Flame

signalword

Danger

hcodes

Hazard Classifications

Flam. Liq. 2

Storage Class

3 - Flammable liquids

wgk_germany

WGK 3


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 10

1 of 10

Ficoll&#174; PM 400 Cytiva 17-0300-50, pack of 500&#160;g

GE17-0300-50

Ficoll® PM 400

Ficoll&#174; PM 400 Cytiva 17-0300-10, pack of 100&#160;g

GE17-0300-10

Ficoll® PM 400

(&#8722;)-Arctigenin &#8805;95% (LC/MS-ELSD)

Sigma-Aldrich

SMB00075

(−)-Arctigenin

Ficoll&#174; 400 BioXtra, for molecular biology, lyophilized powder

Sigma-Aldrich

F2637

Ficoll® 400

Ficoll&#174; 400 lyophilized powder, Type 400-DL, BioReagent, suitable for cell culture

Sigma-Aldrich

F8016

Ficoll® 400

Histopaque&#174;-1119 sterile-filtered, density: 1.119&#160;g/mL

Sigma-Aldrich

11191

Histopaque®-1119

Ficoll&#174; 400

Sigma-Aldrich

F9378

Ficoll® 400

Sigma-Aldrich

Sigma-Aldrich

10831

Histopaque®-1083

Stanislav Pantelyushin et al.
Cancers, 13(4) (2021-03-07)
Rodent cancer models have limitations in predicting efficacy, tolerability and accompanying biomarkers of ICIs in humans. Companion dogs suffering from neoplastic diseases have gained attention as a highly relevant translational disease model. Despite successful reports of PD-1/PD-L1 blockade in dogs
Amalesh Nanda et al.
Annals of laboratory medicine, 40(5), 390-397 (2020-04-21)
The effect of the interplay among inflammation, angiogenesis, extracellular matrix (ECM) degradation, and oxidative stress (OS) on the pathogenesis of endometriosis remains unclear. Previously, we demonstrated the role of OS in endometriosis. Here, we performed a comprehensive investigation of several
Mehdi Hassanpour et al.
Stem cell research & therapy, 11(1), 139-139 (2020-03-29)
To date, many attempts are employed to increase the regenerative potential of stem cells. In this study, we evaluated the hypothesis of whether an autophagy modulation could alter differentiation potency of CD146+ cells into mature pericyte, endothelial, and cardiomyocyte lineage.
Matthew A Lakins et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 26(15), 4154-4167 (2020-04-30)
With the increased prevalence in checkpoint therapy resistance, there remains a significant unmet need for additional therapies for patients with relapsing or refractory cancer. We have developed FS222, a bispecific tetravalent antibody targeting CD137 and PD-L1, to induce T-cell activation
Jingyong Li et al.
Arteriosclerosis, thrombosis, and vascular biology, 39(3), 446-458 (2019-01-18)
Objective- Inflammation occurs during the progression of abdominal aortic aneurysm (AAA). IL (interleukin)-33 is a pleiotropic cytokine with multiple immunomodulatory effects, yet its role in AAA remains unknown. Approach and Results- Immunoblot, immunohistochemistry, and immunofluorescent staining revealed increased IL-33 expression

Protocols

Ficoll 400® is a non-ionic polymer with high hydrophilicity and water solubility, suitable for various biological applications.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service